177 related articles for article (PubMed ID: 35404513)
1. Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity.
Kvitne KE; Krogstad V; Wegler C; Johnson LK; Kringen MK; Hovd MH; Hertel JK; Heijer M; Sandbu R; Skovlund E; Artursson P; Karlsson C; Andersson S; Andersson TB; Hjelmesaeth J; Åsberg A; Jansson-Löfmark R; Christensen H; Robertsen I
Br J Clin Pharmacol; 2022 Sep; 88(9):4121-4133. PubMed ID: 35404513
[TBL] [Abstract][Full Text] [Related]
2. Short- and long-term effects of body weight loss following calorie restriction and gastric bypass on CYP3A-activity - a non-randomized three-armed controlled trial.
Kvitne KE; Robertsen I; Skovlund E; Christensen H; Krogstad V; Wegler C; Angeles PC; Wollmann BM; Hole K; Johnson LK; Sandbu R; Artursson P; Karlsson C; Andersson S; Andersson TB; Hjelmesaeth J; Jansson-Löfmark R; Åsberg A
Clin Transl Sci; 2022 Jan; 15(1):221-233. PubMed ID: 34435745
[TBL] [Abstract][Full Text] [Related]
3. Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight Individuals.
Kvitne KE; Hovd M; Johnson LK; Wegler C; Karlsson C; Artursson P; Andersson S; Sandbu R; Hjelmesæth J; Skovlund E; Jansson-Löfmark R; Christensen H; Åsberg A; Robertsen I
Clin Pharmacokinet; 2024 Jan; 63(1):109-120. PubMed ID: 37993699
[TBL] [Abstract][Full Text] [Related]
4. Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity.
Kvitne KE; Åsberg A; Johnson LK; Wegler C; Hertel JK; Artursson P; Karlsson C; Andersson S; Sandbu R; Skovlund E; Christensen H; Jansson-Löfmark R; Hjelmesaeth J; Robertsen I
Clin Transl Sci; 2022 Nov; 15(11):2685-2696. PubMed ID: 36037309
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic Roux-en-Y gastric bypass surgery influenced pharmacokinetics of several drugs given as a cocktail with the highest impact observed for CYP1A2, CYP2C8 and CYP2E1 substrates.
Puris E; Pasanen M; Ranta VP; Gynther M; Petsalo A; Käkelä P; Männistö V; Pihlajamäki J
Basic Clin Pharmacol Toxicol; 2019 Aug; 125(2):123-132. PubMed ID: 30916845
[TBL] [Abstract][Full Text] [Related]
6. Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity.
Flancbaum L; Choban PS; Bradley LR; Burge JC
Surgery; 1997 Nov; 122(5):943-9. PubMed ID: 9369895
[TBL] [Abstract][Full Text] [Related]
7. Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance.
Hovd M; Robertsen I; Johnson LK; Krogstad V; Wegler C; Kvitne KE; Kringen MK; Skovlund E; Karlsson C; Andersson S; Artursson P; Sandbu R; Hjelmesæth J; Åsberg A; Jansson-Löfmark R; Christensen H
Clin Pharmacokinet; 2023 May; 62(5):725-735. PubMed ID: 36988826
[TBL] [Abstract][Full Text] [Related]
8. Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies.
Desrivot J; Van Kaem T; Allamassey L; Helmer E
Clin Pharmacol Drug Dev; 2021 Sep; 10(9):1007-1017. PubMed ID: 33955686
[TBL] [Abstract][Full Text] [Related]
9. Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity.
Rodríguez-Morató J; Goday A; Langohr K; Pujadas M; Civit E; Pérez-Mañá C; Papaseit E; Ramon JM; Benaiges D; Castañer O; Farré M; de la Torre R
Sci Rep; 2019 Dec; 9(1):20405. PubMed ID: 31892725
[TBL] [Abstract][Full Text] [Related]
10. Energy Metabolic Adaptation and Cardiometabolic Improvements One Year After Gastric Bypass, Sleeve Gastrectomy, and Gastric Band.
Tam CS; Redman LM; Greenway F; LeBlanc KA; Haussmann MG; Ravussin E
J Clin Endocrinol Metab; 2016 Oct; 101(10):3755-3764. PubMed ID: 27490919
[TBL] [Abstract][Full Text] [Related]
11. Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis.
Jenkins J; Williams D; Deng Y; Collins DA; Kitchen VS
Eur J Clin Pharmacol; 2010 Jan; 66(1):67-76. PubMed ID: 19756558
[TBL] [Abstract][Full Text] [Related]
12. Conversion of standard Roux-en-Y gastric bypass to distal bypass for weight loss failure and metabolic syndrome: 3-year follow-up and evolution of technique to reduce nutritional complications.
Ghiassi S; Higa K; Chang S; Ma P; Lloyd A; Boone K; DeMaria EJ
Surg Obes Relat Dis; 2018 May; 14(5):554-561. PubMed ID: 29567059
[TBL] [Abstract][Full Text] [Related]
13. Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.
Yeh RF; Gaver VE; Patterson KB; Rezk NL; Baxter-Meheux F; Blake MJ; Eron JJ; Klein CE; Rublein JC; Kashuba AD
J Acquir Immune Defic Syndr; 2006 May; 42(1):52-60. PubMed ID: 16639344
[TBL] [Abstract][Full Text] [Related]
14. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
Lips MA; de Groot GH; van Klinken JB; Aarts E; Berends FJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Willems van Dijk K; Pijl H
Clin Endocrinol (Oxf); 2014 Jun; 80(6):834-42. PubMed ID: 23711328
[TBL] [Abstract][Full Text] [Related]
15. Surgery for weight loss in adults.
Colquitt JL; Pickett K; Loveman E; Frampton GK
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003641. PubMed ID: 25105982
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
17. Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial.
Schmidt JB; Pedersen SD; Gregersen NT; Vestergaard L; Nielsen MS; Ritz C; Madsbad S; Worm D; Hansen DL; Clausen TR; Rehfeld JF; Astrup A; Holst JJ; Sjödin A
Int J Obes (Lond); 2016 Feb; 40(2):281-90. PubMed ID: 26303352
[TBL] [Abstract][Full Text] [Related]
18. The Benefits of Banded over Non-banded Roux-en-Y Gastric Bypass in Patients with Morbid Obesity: a Multi-center Study.
Jense MTF; Palm-Meinders IH; Sigterman-Nelissen R; Boerma EG; Liem RSL; Swank DJ; Greve JWM
Obes Surg; 2022 Jun; 32(6):1856-1863. PubMed ID: 35366739
[TBL] [Abstract][Full Text] [Related]
19. Primary Roux-en-Y Gastric Bypass Results in Greater Weight Loss at 15-Year Follow-Up Compared with Secondary Roux-en-Y Gastric Bypass After Failure of Gastric Band or Mason McLean Vertical Gastroplasty.
Etienne JH; Petrucciani N; Goetschy M; Gugenheim J; Schneck AS; Iannelli A
Obes Surg; 2020 Oct; 30(10):3655-3668. PubMed ID: 32488745
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of a supervised inpatient low-calorie diet program for massive weight loss prior to RYGB in superobese patients.
Huerta S; Li Z; Anthony T; Livingston EH
Obes Surg; 2010 Feb; 20(2):173-80. PubMed ID: 19862584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
